Oct 1st, 2014
The Office of Inspector General (OIG) issued on September 18 a Special Advisory Bulletin (SAB) and an Office of Evaluations and Inspections (OEI) report that discussed the potential Anti-kickback issues for pharmaceutical companies and pharmacies associated with offering co-payment and/or discount coupons. The SAB defines co-payment coupons as “any form of direct support offered by a manufacturer ...